FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2592766683> ?p ?o ?g. }

• W2592766683 abstract "Abstract Abstract 3174 Background: As survival rates continue to improve for patients with haematological malignancy, there is an increasing emphasis on quality of life (QOL) as an important treatment outcome. Long-term survivors can experience a variety of adverse physical late effects of cancer therapy. However, psychological, e.g. depression and anxiety, and social problems can also have profoundly adverse effects on patients' QOL that may not be adequately addressed in the management of long-term survivors. In this retrospective cohort study of late effects in 718 British survivors of lymphoma and leukaemia (5–40 years since diagnosis), treated at a single centre, participants completed a series of questionnaires including the Hospital Anxiety and Depression Scale (HADS) and the Impact of Cancer (IOCv2) scale, which is a QOL instrument specifically designed to measure both positive and negative impacts of cancer in long-term survivors. Objective: To examine the association between depression and anxiety (HADS) and QOL (IOCv2). Patients and Methods: Ethical approval obtained from the National Research Ethics Service Ref: 11/NE/0095 All patients, aged ≥18 years at time of entry into study, with a confirmed diagnosis of haematological malignancy and alive ≥5 years since initial diagnosis, and who had received treatment at St. Bartholomew's Hospital, London (n=1,288) were sent a questionnaire comprising socio-demographic details and a series of medical and psychosocial measures, including IOCv2 and HADS. Responses were received from 718 (response rate = 56%) patients (280 Hodgkin's Lymphoma (HL), 326 Non-Hodgkin's lymphoma (NHL) [109 Diffuse Large B- Lymphoma (DLBCL), 128 Follicular Lymphoma (FL), 89 other NHL (ONHL)], and 112 Acute Leukaemia (AL)). Statistical Analysis: Spearman rank correlation between HADS scores and positive and negative scales of IOCv2 were examined, and, where significant, mean scores for each scale/domain were compared between groups scoring >15 on HADS (indicating a high possibility of clinical depressive or anxiety disorder) and ≤15, using multivariable linear regression analysis and adjusting for age, years since diagnosis, gender, relationship status and ethnicity in HL, DLBCL, FL/ONHL and AL respectively. Bonferroni corrections were used for multiple testing. Results: Fifteen percent (HL 14%; DLBCL 15%, FL/ONHL 18%; AL 16%) of participants had HADS scores >15 indicative of a clinical mood or anxiety disorder. There was no statistically significant difference between HADS scores across the diagnostic groups (P=0.65). There was a significant correlation between HADS scores and IOC negative impact scale scores (r=0.68, P<0.001) and all negative impact domains (r≥0.39, P<0.001) but no correlation with positive impact scale scores. Regression analysis of IOC negative impact scale scores showed significantly higher values (P<0.001) in patients with HADS >15 in all diagnostic groups after adjusting for current age, years since diagnosis, gender, relationship status and ethnicity (total 2.87 vs. 3.83; HL 3.24 vs. 3.90; DLBCL 3.28 vs. 4.40; FL/ONHL 2.81 vs. 3.90; AL 2.03 vs. 3.24). Similar significant results (P≤0.02) were also observed at the negative domain level. In the adjusted analyses, those who were in a relationship had significantly lower IOC negative impact scores than those who were not in a relationship in HL (P=0.01) and DLBCL, (P<0.05). In survivors of FL/ONHL and DLBCL, there was a significant reduction in mean negative impact scores of 0.2 per 10 years increase in survival time (P<0.01). Also, among HL survivors, there was a significant reduction in mean negative impact scores of 0.08 per 10 years increase in current age. Conclusions: Levels of depression and anxiety symptoms are higher in long-term cancer survivors than in the general population and strongly correlated with negative impact of cancer in all types of haematological malignancy, regardless of prognosis. Other factors, such as age, years since diagnosis and degree of social support, are also contributory and a greater understanding of how these interact is needed to improve quality of life and other healthcare needs of long-term survivors. Disclosures: Gribben: Celgene: Honoraria; Roche: Honoraria; Merck: Honoraria; Mundipharma: Honoraria; Pharmacyclics: Honoraria." @default.
• W2592766683 created "2017-03-16" @default.
• W2592766683 creator A5008920583 @default.
• W2592766683 creator A5018704169 @default.
• W2592766683 creator A5029723036 @default.
• W2592766683 creator A5051410187 @default.
• W2592766683 creator A5052364155 @default.
• W2592766683 creator A5054177872 @default.
• W2592766683 creator A5057059839 @default.
• W2592766683 creator A5067154165 @default.
• W2592766683 creator A5067573670 @default.
• W2592766683 creator A5067699501 @default.
• W2592766683 creator A5067835811 @default.
• W2592766683 creator A5069757680 @default.
• W2592766683 creator A5091780580 @default.
• W2592766683 date "2012-11-16" @default.
• W2592766683 modified "2023-09-29" @default.
• W2592766683 title "The Relationship of Depression and Anxiety and Impact of Cancer in Long-Term Survivors of Haematological Malignancy." @default.
• W2592766683 doi "https://doi.org/10.1182/blood.v120.21.3174.3174" @default.
• W2592766683 hasPublicationYear "2012" @default.
• W2592766683 type Work @default.
• W2592766683 sameAs 2592766683 @default.
• W2592766683 citedByCount "0" @default.
• W2592766683 crossrefType "journal-article" @default.
• W2592766683 hasAuthorship W2592766683A5008920583 @default.
• W2592766683 hasAuthorship W2592766683A5018704169 @default.
• W2592766683 hasAuthorship W2592766683A5029723036 @default.
• W2592766683 hasAuthorship W2592766683A5051410187 @default.
• W2592766683 hasAuthorship W2592766683A5052364155 @default.
• W2592766683 hasAuthorship W2592766683A5054177872 @default.
• W2592766683 hasAuthorship W2592766683A5057059839 @default.
• W2592766683 hasAuthorship W2592766683A5067154165 @default.
• W2592766683 hasAuthorship W2592766683A5067573670 @default.
• W2592766683 hasAuthorship W2592766683A5067699501 @default.
• W2592766683 hasAuthorship W2592766683A5067835811 @default.
• W2592766683 hasAuthorship W2592766683A5069757680 @default.
• W2592766683 hasAuthorship W2592766683A5091780580 @default.
• W2592766683 hasConcept C118552586 @default.
• W2592766683 hasConcept C121608353 @default.
• W2592766683 hasConcept C126322002 @default.
• W2592766683 hasConcept C139719470 @default.
• W2592766683 hasConcept C150966472 @default.
• W2592766683 hasConcept C159110408 @default.
• W2592766683 hasConcept C162324750 @default.
• W2592766683 hasConcept C187212893 @default.
• W2592766683 hasConcept C197934379 @default.
• W2592766683 hasConcept C2776867660 @default.
• W2592766683 hasConcept C2778739829 @default.
• W2592766683 hasConcept C2779399171 @default.
• W2592766683 hasConcept C2779951463 @default.
• W2592766683 hasConcept C558461103 @default.
• W2592766683 hasConcept C71924100 @default.
• W2592766683 hasConcept C72563966 @default.
• W2592766683 hasConceptScore W2592766683C118552586 @default.
• W2592766683 hasConceptScore W2592766683C121608353 @default.
• W2592766683 hasConceptScore W2592766683C126322002 @default.
• W2592766683 hasConceptScore W2592766683C139719470 @default.
• W2592766683 hasConceptScore W2592766683C150966472 @default.
• W2592766683 hasConceptScore W2592766683C159110408 @default.
• W2592766683 hasConceptScore W2592766683C162324750 @default.
• W2592766683 hasConceptScore W2592766683C187212893 @default.
• W2592766683 hasConceptScore W2592766683C197934379 @default.
• W2592766683 hasConceptScore W2592766683C2776867660 @default.
• W2592766683 hasConceptScore W2592766683C2778739829 @default.
• W2592766683 hasConceptScore W2592766683C2779399171 @default.
• W2592766683 hasConceptScore W2592766683C2779951463 @default.
• W2592766683 hasConceptScore W2592766683C558461103 @default.
• W2592766683 hasConceptScore W2592766683C71924100 @default.
• W2592766683 hasConceptScore W2592766683C72563966 @default.
• W2592766683 hasLocation W25927666831 @default.
• W2592766683 hasOpenAccess W2592766683 @default.
• W2592766683 hasPrimaryLocation W25927666831 @default.
• W2592766683 hasRelatedWork W1564833780 @default.
• W2592766683 hasRelatedWork W2047008092 @default.
• W2592766683 hasRelatedWork W2055409716 @default.
• W2592766683 hasRelatedWork W2103604667 @default.
• W2592766683 hasRelatedWork W2126904741 @default.
• W2592766683 hasRelatedWork W2320404106 @default.
• W2592766683 hasRelatedWork W2395281268 @default.
• W2592766683 hasRelatedWork W2564186159 @default.
• W2592766683 hasRelatedWork W2572927045 @default.
• W2592766683 hasRelatedWork W2737831319 @default.
• W2592766683 hasRelatedWork W2896564158 @default.
• W2592766683 hasRelatedWork W2901598820 @default.
• W2592766683 hasRelatedWork W2991387429 @default.
• W2592766683 hasRelatedWork W3025584464 @default.
• W2592766683 hasRelatedWork W3033023350 @default.
• W2592766683 hasRelatedWork W3072775743 @default.
• W2592766683 hasRelatedWork W3092042397 @default.
• W2592766683 hasRelatedWork W3138668294 @default.
• W2592766683 hasRelatedWork W3142229484 @default.
• W2592766683 hasRelatedWork W3151145139 @default.
• W2592766683 isParatext "false" @default.
• W2592766683 isRetracted "false" @default.
• W2592766683 magId "2592766683" @default.
• W2592766683 workType "article" @default.